MedTrace Logo

Atrial Natriuretic Peptide in Assessing Fluid Status

NCT05070819 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 30

Last updated 2025-06-08

Study results available
· View outcomes & findings →

Summary

Biomarkers can play a significant role in fluid status assessment intraoperatively.

Conditions

  • Fluid Overload
  • Fluid Loss
  • Volume Overload
  • Cardiac Disease
  • Cardiac Output, Low
  • Cardiac Output, High

Interventions

DIAGNOSTIC_TEST

pro-ANP

pro-ANP samples and fluid status assessment with functional tests (Teboul test) will be used 8 times intraoperatively.

Sponsors & Collaborators

  • Petrovsky National Research Centre of Surgery

    lead OTHER

Principal Investigators

  • Boris Akselrod, Ph.D · Petrovsky NRCS

Study Design

Allocation
NA
Purpose
DIAGNOSTIC
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-09-23
Primary Completion
2022-03-28
Completion
2022-04-07

Countries

  • Russia

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05070819 on ClinicalTrials.gov